Clinical trial Recruiting at 11 sites Interventional Ages 18 and up

ReDS-guided decongestion for people hospitalized with heart failure

Official title: ReDS-guided Decongestion Strategy in Patients Hospitalized for Heart Failure: the ReDS-SAFE HF II Trial

Run by Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal · NCT07484009 · Data updated 2026-11-12

This test will see if using a ReDS chest sensor to guide fluid removal helps adults hospitalized for heart failure have fewer heart-related problems in the month after discharge.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment1014 (estimated)
SponsorFundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Academic / other
Locations25 sites (Madrid, Madrid and 24 other locations)
StatusRecruiting
StartedJanuary 29, 2026
Main results expectedJune 30, 2027
Study endsAugust 31, 2027
Registry record updatedMarch 19, 2026
Trial IDNCT07484009 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults hospitalized primarily for heart failure with clinical signs of congestion and admission NT-proBNP >1000 pg/L or BNP >300 pg/L, and with height and BMI within the ReDS-approved ranges, are ideal candidates.

Probably not a fit

Patients who need inotropes or vasopressors, have mechanical circulatory support or planned cardiac surgery/intervention, have incompatible lung anatomy or height/BMI, severe kidney failure on dialysis, or life expectancy under 12 months are unlikely to benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized interventional study compares a ReDS-guided decongestion strategy to usual care in adults admitted for acute heart failure with signs of congestion and elevated natriuretic peptides. Participants will have daily ReDS measurements during hospitalization and will be randomized to treatment guided by those measurements or to standard care with ReDS data blinded. Investigators will track cardiovascular events in the first 30 days after discharge, and will monitor safety and costs of the approach. Two follow-up visits are scheduled at about 2 weeks and 30 days after discharge to capture outcomes and adverse events.

Why it matters

Potential benefit: If successful, the ReDS-guided approach could reduce early post-discharge heart-related events and help tailor diuretic therapy to decrease rehospitalizations and costs.

How similar studies have gone: Some prior studies have shown ReDS can detect lung fluid and guide outpatient management, but using ReDS-guided decongestion in hospitalized patients to reduce early post-discharge events is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Hospitalized due to heart failure as the main reason, including the presence of symptoms and signs of congestion, regardless of the left ventricular ejection fraction (LVEF).
2. NT-proBNP greater than 1000 pg/L or BNP greater than 300 pg/L upon admission.

Exclusion Criteria:

1. Height less than 150 cm or greater than 190 cm or body mass index (BMI) less than 22 or greater than 39, conditions where the use of ReDS is not approved.
2. Patients requiring inotropes (levosimendan is allowed) or vasopressors upon admission, with mechanical support, or heart transplant recipients.
3. Any malformation or variant affecting the right lung anatomy (e.g., a pacemaker).
4. Patients with any heart disease requiring a planned surgical intervention (CABG, valve disease, or other) or percutaneous (TAVR, STE-ACS, mitral or tricuspid valve repair, CRT) during the clinical trial.
5. Chronic kidney disease with a GFR \<20 or on hemodialysis.
6. Life expectancy less than 12 months due to non-cardiological origin.
7. Participation in another clinical trial with intervention.

Where it's running

  • Ramón y Cajal University Hospital
    Madrid, Madrid, Spain
    Recruiting
  • Bellvitge University Hospital
    Barcelona, Spain
    Recruiting
  • Hospital del Mar
    Barcelona, Spain
    Recruiting
  • Reina Sofía University Hospital
    Córdoba, Spain
    Recruiting
  • Dr Josep Trueta University Hospital
    Girona, Spain
    Recruiting
  • 12 de Octubre University Hospital
    Madrid, Spain
    Recruiting
Show 19 more locations
  • La Paz University Hospital
    Madrid, Spain
    Recruiting
  • Puerta de Hierro Majadahonda University Hospital
    Madrid, Spain
    Recruiting
  • Virgen de la Victoria University Hospital
    Málaga, Spain
    Recruiting
  • San Juan Despí Moisès Broggi Hospital
    Sant Joan Despí, Spain
    Recruiting
  • Complejo Hospitalario Universitario de Santiago
    Santiago de Compostela, Spain
    Recruiting
  • Arnau de Vilanova University Hospital
    Barcelona, Spain
    Not yet recruiting
  • Hospital Clinic
    Barcelona, Spain
    Not yet recruiting
  • Vall d'Hebrón University Hospital
    Barcelona, Spain
    Not yet recruiting
  • Clínico San Carlos University Hospital
    Madrid, Spain
    Not yet recruiting
  • Fundación Jiménez Díaz University Hospital
    Madrid, Spain
    Not yet recruiting
  • Gregorio Marañón University Hospital
    Madrid, Spain
    Not yet recruiting
  • La Princesa University Hospital
    Madrid, Spain
    Not yet recruiting
  • Virgen de la Arrixaca
    Murcia, Spain
    Not yet recruiting
  • Complejo Asistencial Universitario de Salamanca
    Salamanca, Spain
    Not yet recruiting
  • Marqués de Valdecilla University Hospital
    Santander, Spain
    Not yet recruiting
  • Virgen de la Macarena University Hospital
    Seville, Spain
    Not yet recruiting
  • Sant Joan XXIII University Hospital
    Tarragona, Spain
    Not yet recruiting
  • Hospital General Universitario de Toledo
    Toledo, Spain
    Not yet recruiting
  • Clínico University Hospital
    Valencia, Spain
    Not yet recruiting

Study contacts

  • Principal investigator: Jesús Álvarez-García, MD, PhD — Ramón y Cajal University Hospital, Madrid, Spain
  • Study coordinator: Jesús Álvarez-García, MD, PhD
  • Email: jalvarezg82@gmail.com
  • Phone: 34 667495661

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.